Does SSRI medication effectively treat depression?
Strong EvidenceYES
Strong evidence from the largest network meta-analysis (Cipriani 2018, 522 trials) confirms SSRIs are more effective than placebo for depression. However, the clinical significance of the effect is debated, particularly for mild-to-moderate cases where the drug-placebo difference is small.
The Verdict
Strong evidence from the largest network meta-analysis (Cipriani 2018, 522 trials) confirms SSRIs are more effective than placebo for depression. However, the clinical significance of the effect is debated, particularly for mild-to-moderate cases where the drug-placebo difference is small.
What the Evidence Shows
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants worldwide. Cipriani et al.'s landmark 2018 network meta-analysis in The Lancet analyzed 522 trials comprising 116,477 participants and found all 21 antidepressants studied were more effective than placebo, with SSRIs showing consistent efficacy. However, the magnitude of benefit is contested. Fournier et al. (2010) found that the drug-placebo difference was clinically meaningful only for severe depression (Hamilton scores >25), raising questions about prescribing for milder cases. Kirsch et al. (2008) similarly argued that for most patients, the difference falls below clinical significance thresholds. The debate intensified with Moncrieff et al.'s 2022 umbrella review challenging the serotonin hypothesis of depression itself, though this does not directly negate SSRI efficacy (drugs can work through mechanisms different from their purported target). In clinical practice, SSRIs help approximately 40-60% of patients achieve meaningful response, compared to 30-40% on placebo. The number needed to treat (NNT) is approximately 7-8 for response. Side effects including sexual dysfunction, emotional blunting, and discontinuation symptoms must be weighed against benefits. Combined SSRI and psychotherapy approaches typically outperform either alone.
Evidence Quality
5
Meta-Analyses
522
RCTs
15
Observational
Important Caveats
- ⚠️ Drug-placebo difference is small for mild to moderate depression
- ⚠️ Response rates are 40-60% meaning many patients do not benefit
- ⚠️ Side effects including sexual dysfunction affect quality of life
- ⚠️ The serotonin hypothesis of depression has been challenged
- ⚠️ Combined therapy with psychotherapy typically outperforms medication alone
Population Studied
Adults with major depressive disorder across severity levels; 522 trials with 116,477 participants in the largest meta-analysis
Dosage
Standard SSRI doses vary by drug: fluoxetine 20mg, sertraline 50-200mg, escitalopram 10-20mg daily
Duration
Clinical trials typically 6-12 weeks; maintenance treatment often recommended for 6-12 months after remission
Supporting Studies (3)
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
Meta-AnalysisCipriani A, Furukawa TA, Salanti G, et al. · The Lancet (2018)
All 21 antidepressants were more effective than placebo. Network meta-analysis of 522 trials (116,477 participants) confirmed SSRIs are effective for acute depression treatment.
View paper (DOI) →Antidepressant drug effects and depression severity: a patient-level meta-analysis
Meta-AnalysisFournier JC, DeRubeis RJ, Hollon SD, et al. · JAMA (2010)
The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms. True drug effects are nonexistent to negligible among depressed patients with mild symptoms.
View paper (DOI) →Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration
Meta-AnalysisKirsch I, Deacon BJ, Huedo-Medina TB, et al. · PLoS Medicine (2008)
Drug-placebo differences in antidepressant efficacy increase as a function of baseline severity but remain relatively small even for severely depressed patients. The relationship between initial severity and antidepressant efficacy is attributable to decreased responsiveness to placebo among very severely depressed patients.
View paper (DOI) →Contradicting Studies (1)
The serotonin theory of depression: a systematic umbrella review of the evidence
Systematic ReviewMoncrieff J, Cooper RE, Stockmann T, et al. · Molecular Psychiatry (2022)
Comprehensive umbrella review found no consistent evidence that depression is associated with serotonin abnormalities or that SSRIs work by correcting a serotonin imbalance.
Why this disagrees:
While this study does not directly test SSRI efficacy, it undermines the mechanistic rationale for their use. If depression is not caused by serotonin deficiency, SSRIs may work through non-specific mechanisms (placebo amplification, emotional blunting) rather than correcting a biological deficit. This challenges the narrative used to prescribe them.
Related Claims
Does exercise reduce anxiety symptoms?
Strong EvidenceStrong evidence from large meta-analyses confirms exercise significantly reduces anxiety symptoms with small-to-moderate effect sizes. Benefits are observed across exercise types and anxiety conditions. Exercise is recommended as an adjunct treatment in clinical guidelines.
Does practicing gratitude improve psychological wellbeing?
Moderate EvidenceModerate evidence suggests gratitude interventions (journaling, letters, exercises) can improve subjective wellbeing and life satisfaction. However, meta-analyses show effect sizes are smaller than popularly claimed, and benefits may be driven partly by expectation effects and publication bias.
Does meditation reduce cortisol levels?
Moderate EvidenceModerate evidence suggests mindfulness meditation can reduce cortisol levels, though effect sizes are generally small to moderate and study quality varies considerably. The relationship appears real but is not as robust as often claimed in popular media.